Capecitabine for hormone receptor-positive versus hormone receptor-negative breast cancer

Volume: 2021, Issue: 5
Published: May 26, 2021
Abstract
Retrospective analyses suggest that capecitabine may carry superior activity in hormone receptor-positive relative to hormone receptor-negative metastatic breast cancer. This review examined the veracity of that finding and explored whether this differential activity extends to early breast cancer.To assess effects of chemotherapy regimens containing capecitabine compared with regimens not containing capecitabine for women with hormone...
Paper Details
Title
Capecitabine for hormone receptor-positive versus hormone receptor-negative breast cancer
Published Date
May 26, 2021
Volume
2021
Issue
5
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.